Ireland gudaheeda, warbixin ay soo saartay Hay'adda Macluumaadka Caafimaadka iyo Tayada Irishka (HIQA) ayaa lagu soo gabagabeeyay in sigaarka elektaroonigga ah uu yahay habka ugu waxtarka badan ee joojinta sigaarka. Warbixintan caanka ah ayaa noqon doonta mid taariikhi ah maadaama ay tahay tii ugu horeysay ee nooceeda ah ee Yurub.
IRELAND AYAA SIISAY WARBIXINTAN HOR HORUMAR AH
Marka loo eego falanqaynta rasmiga ah ee ugu horreysa ee nooceeda ah ee Yurub, sigaarka elektaroonigga ah waa hab kharash-ku-ool ah oo lagu caawiyo dadka sigaarka cabba inay joojiyaan sigaarka. Falanqayntan ayaa nooga timid Ireland oo hadda ah dalka keliya ee ku jira Midowga Yurub ee ku daray sigaarka elektaroonigga ah qiimeyn ay dawladu hogaaminayso oo muwaadiniinta ku wargelinaysa habka ugu wanaagsan ee loo joojin karo sigaarka.
Maamulka Caafimaadka iyo Macluumaadka tayada Dublin (HIQA) waxay ogaadeen in dad aad u badan ay isticmaalayaan sigaarka elektaroonigga ah sababtoo ah waxay runtii laaday caadooyinkoodii. Sida laga soo xigtay iyaga, sigaarka elektaroonigga ah waa faa'iido wuxuuna badbaadin karaa malaayiin hanti dadweyne sanad kasta.
Si kastaba ha ahaatee, maamulka caafimaadka, oo aan weli daabicin warbixinteedii ugu dambeysay, waxay aqoonsan tahay in saameynta muddada dheer ee isticmaalka sigaarka elektarooniga ah aan weli la aasaasin. Waxay sheegtay in sigaarka elektaroonigga ah uu noqon doono hab wax ku ool ah oo lagu caawinayo dadka inay joojiyaan sigaarka haddii isticmaalkeeda lagu daro daawada varenicline (Champix) ama xanjo nikotiinta, kuwa neefta lagu nuugo ama balastarka. Nasiib darro, samaynta isku-dhafkan ayaa ka qaalisanaan doona isticmaalka sigaarka elektaroonigga ah.
Wixii ah Dr. Mairin Ryan, Agaasimaha Qiimaynta Tignoolajiyada Caafimaadka ee HIQA,” Waxaa weli jira heer sare oo hubaal la'aan ah oo ku saabsan dhinaca kiliinikada iyo waxtarka qiimaha sigaarka elektaroonigga ah. isagoo ku daray, si kastaba ha ahaatee, " Falanqaynta Hiqa waxay muujinaysaa in korodhka isticmaalka sigaarka elektaroonigga ah ee gargaarka joojinta sigaarka ay kordhinayso guusha marka loo eego xaaladda jirta ee Ireland. Tani waxay noqon doontaa faa'iido, waxtarka sigaarka elektaroonigga ah waxaa lagu xaqiijiyay daraasado kale. »
MAXAA WARBIXINTA HIQA KA BANDHIGAY
:: Varenicline (Champix) waxay ahayd daawada kaliya ee waxtarka leh ee joojinta sigaarka (in ka badan laba jeer iyo badh ka waxtar badan daawooyinka kale).
:: Varenicline (Champix) oo lagu daray daawaynta beddelka nicotine-ka waxay ka waxtar badan tahay dawada la'aantiis in ka badan saddex jeer iyo badh;
:: Sigaarka E-sigaarka ayaa labanlaab ka waxtar badnaa joojinta daawaynta la'aan (natiijo ku salaysan laba tijaabo oo tiro yar oo ka qaybgalayaal ah).
Maamulka Caafimaadka iyo Macluumaadka tayada Dublin (HIQA) waxay samaynaysaa natiijooyinkeeda diyaar u ah la tashi dadweyne ka hor inta aan lagu heshiin warbixinta kama dambaysta ah, taas oo loo bandhigi doono Simon Harris, Wasiirka Caafimaadka Ireland.
FYI, ku dhawaad saddex meelood meel dadka sigaarka cabba ee Irish ayaa isticmaala sigaarka elektaroonigga ah sigaarka, Ireland waxay ku bixisaa in ka badan 40 milyan oo Yuuro (£34 milyan) sanad walba si ay uga caawiso dadka joojinta sigaarka.
Warbixinta HIQA ayaa sheegtay in kororka isticmaalka Champix oo lagu daray daawaynta beddelka nicotine-ku ay "kharash wax ku ool ah yeelan doonto" laakiin waxay ku kici kartaa ku dhawaad siddeed milyan oo Yuuro (£ 6,8 milyan) kharashaadka daryeelka caafimaadka. Waxaa la ogaaday in kororka isticmaalka sigaarka elektaroonigga ah uu hoos u dhigi doono biilka 2,6 milyan oo Yuuro (£2,2 milyan) sannadkii.
